• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Reimbursement Achievable for Biologics in Psoriasis

The January FDA clearance of Biogen Inc.'s Amevive (alefacept) for the treatment of moderate-to-severe chronic plaque psoriasis officially ushered in the era of biologic treatments for dermatologists.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!
Related Videos
Dr. Suneel Chilukuri
Health Care Impacts on Gender and Sexual Minority Patients
Related Content
Time in the Market: What History Tells Us About Investing During Volatile Markets
June 4th 2025

Time in the Market: What History Tells Us About Investing During Volatile Markets

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice
February 18th 2021

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

How to Integrate Psychiatry Tools for Optimized Dermatologic Care
June 2nd 2025

How to Integrate Psychiatry Tools for Optimized Dermatologic Care

Track It Right: The Key to PA Business Success
June 2nd 2025

Track It Right: The Key to PA Business Success

Workflow Wins For Even the Busiest Practices
May 31st 2025

Workflow Wins For Even the Busiest Practices

Practice and Personal Planning: Tactics That Reduce Taxes and Protect Assets
May 15th 2025

Practice and Personal Planning: Tactics That Reduce Taxes and Protect Assets

© 2025 MJH Life Sciences

All rights reserved.